XBiotech Inc.
XBIT
$3.28
$0.4013.89%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -56.90% | -41.22% | -23.18% | 1.85% | 25.36% |
| Total Depreciation and Amortization | 0.06% | -0.74% | -15.67% | -26.16% | -33.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 431.92% | 2,075.25% | 12.18% | -55.31% | -82.59% |
| Change in Net Operating Assets | -153.66% | -64.63% | 24.26% | -36.85% | -64.22% |
| Cash from Operations | -65.36% | -50.93% | -29.69% | -45.56% | -26.32% |
| Capital Expenditure | -260.22% | -252.24% | -85.25% | -42.09% | 38.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 197.71% | 197.71% | 197.71% |
| Cash from Investing | -102.12% | -102.31% | 195.25% | 196.09% | 196.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,900.00% | 3,240.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | -- | -- |
| Cash from Financing | 116,211.11% | 113,066.67% | 72,300.00% | -- | -- |
| Foreign Exchange rate Adjustments | -11,919.57% | -102.06% | -466.50% | -48.49% | 95.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -164.02% | -145.82% | 154.78% | 161.20% | 153.61% |
